SUVEN LIFESCIENCES Surges by 5%; BSE HEALTHCARE Index Up 0.2%
May 23, 2019 02:54 PM

SUVEN LIFESCIENCES share price has zoomed 5% and is presently trading at Rs 266.

Meanwhile, the BSE HEALTHCARE Index is at 13,433 (up 0.2%).

Among the top Gainers in the BSE HEALTHCARE Index today is SUVEN LIFESCIENCES (up 5.4%).

ALEMBIC PHARMA (down 0.1%) and SYNGENE INTERNATIONAL (down 0.2%) are among the top losers today.

Over the last one year, SUVEN LIFESCIENCES has moved up from Rs 189 to Rs 266, registering a gain of Rs 78 (up 40.0%).

On the other hand, the BSE HEALTHCARE has moved up from 12,830 to 13,433, registering a gain of 603 points (up 3.8%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DIVIS LABORATORIES (up 55.3%), SUVEN LIFESCIENCES (up 40.0%) and IPCA LABS (up 37.9%).

What About the Benchmark Indices?

The BSE Sensex is at 40,125 .

The top gainers among the BSE Sensex stocks today are INDUSIND BANK (up 6.3%), YES BANK (up 2.7%) and ICICI BANK (up 2.7%). Other gainers include HERO MOTOCORP (up 2.4%) and SBI (up 2.1%). The most traded stocks in the BSE Sensex are YES BANK and SBI.

In the meantime, NSE Nifty is at 12,041 . ADANI PORTS & SEZ (up 6.3%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 34,651 to 40,125, registering a gain of 5,474 points (up 12.9%).

SUVEN LIFESCIENCES Financial Update...

SUVEN LIFESCIENCES net profit down at Rs 252 million for the quarter ended December 2018, compared to a loss of Rs 346 million a year ago. Net Sales declined 21.2% to Rs 1.3 billion during the period as against Rs 1.6 billion in October-December 2017.

For the year ended March 2018, SUVEN LIFESCIENCES reported 41.9% increase in net profit to Rs 1.2 billion compared to net profit of Rs 872.0 million during FY17.

Revenue of the company grew 14.8% to Rs 6 billion during FY18.

The current Price to earnings ratio of SUVEN LIFESCIENCES, based on rolling 12 month earnings, stands at 23.3x.